209 related articles for article (PubMed ID: 16220669)
21. Effect of Intravenous or Perivascular Injection of Synthetic Adrenocorticotropic Hormone on Stimulation Test Results in Dogs.
Johnson CM; Kass PH; Cohen TA; Feldman EC
J Vet Intern Med; 2017 May; 31(3):730-733. PubMed ID: 28407319
[TBL] [Abstract][Full Text] [Related]
22. Serum 17alpha-hydroxyprogesterone concentrations during the reproductive cycle in healthy dogs and dogs with hyperadrenocorticism.
Brömel C; Feldman EC; Davidson AP; Nelson RW; Kass PH; Esteller Vico A; Labelle P; Munro CJ; Conley AJ
J Am Vet Med Assoc; 2010 Jun; 236(11):1208-14. PubMed ID: 20513199
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
[TBL] [Abstract][Full Text] [Related]
24. The interpretive contribution of the baseline serum cortisol concentration of the ACTH stimulation test in the diagnosis of pituitary dependent hyperadrenocorticism in dogs.
Nivy R; Refsal KR; Ariel E; Kuzi S; Yas-Natan E; Mazaki-Tovi M
J Vet Intern Med; 2018 Nov; 32(6):1897-1902. PubMed ID: 30334283
[TBL] [Abstract][Full Text] [Related]
25. Steroidogenic response of adrenal tissues after administration of ACTH to dogs with hypercortisolemia.
Frank LA; Schmeitzel LP; Oliver JW
J Am Vet Med Assoc; 2001 Jan; 218(2):214-6. PubMed ID: 11195825
[TBL] [Abstract][Full Text] [Related]
26. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995).
Greco DS; Peterson ME; Davidson AP; Feldman EC; Komurek K
J Am Vet Med Assoc; 1999 May; 214(9):1349-53. PubMed ID: 10319177
[TBL] [Abstract][Full Text] [Related]
27. Plasma concentrations of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependent hyperadrenocorticism.
Bosje JT; Rijnberk A; Mol JA; Voorhout G; Kooistra HS
Domest Anim Endocrinol; 2002 Jun; 22(4):201-10. PubMed ID: 12044610
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
Mack RE; Feldman EC
J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
[TBL] [Abstract][Full Text] [Related]
29. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Angles JM; Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
[TBL] [Abstract][Full Text] [Related]
30. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism.
Dunn KJ; Herrtage ME; Dunn JK
Vet Rec; 1995 Aug; 137(7):161-5. PubMed ID: 8553523
[TBL] [Abstract][Full Text] [Related]
31. Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane.
Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
Domest Anim Endocrinol; 2006 Jul; 31(1):63-75. PubMed ID: 16233969
[TBL] [Abstract][Full Text] [Related]
32. Non-dexamethasone-suppressible, pituitary-dependent hyperadrenocorticism in a dog.
Kemppainen RJ; Zenoble RD
J Am Vet Med Assoc; 1985 Aug; 187(3):276-8. PubMed ID: 4030467
[TBL] [Abstract][Full Text] [Related]
33. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the use of baseline cortisol concentration as a monitoring tool for dogs receiving trilostane as a treatment for hyperadrenocorticism.
Cook AK; Bond KG
J Am Vet Med Assoc; 2010 Oct; 237(7):801-5. PubMed ID: 20919845
[TBL] [Abstract][Full Text] [Related]
35. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism.
Griebsch C; Lehnert C; Williams GJ; Failing K; Neiger R
J Vet Intern Med; 2014; 28(1):160-5. PubMed ID: 24341822
[TBL] [Abstract][Full Text] [Related]
36. Circulating concentration of dexamethasone in healthy dogs, dogs with hyperadrenocorticism, and dogs with nonadrenal illness during dexamethasone suppression testing.
Kemppainen RJ; Peterson ME
Am J Vet Res; 1993 Oct; 54(10):1765-9. PubMed ID: 8250405
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic efficacy of plasma ACTH-measurement by a chemiluminometric assay in canine hyperadrenocorticism].
Zeugswetter F; Pagitz M; Hittmair K; Schwendenwein I
Schweiz Arch Tierheilkd; 2011 Mar; 153(3):111-6. PubMed ID: 21360448
[TBL] [Abstract][Full Text] [Related]
38. Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism.
Wenger M; Sieber-Ruckstuhl NS; Müller C; Reusch CE
Am J Vet Res; 2004 Sep; 65(9):1245-50. PubMed ID: 15478772
[TBL] [Abstract][Full Text] [Related]
39. Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism.
Gould SM; Baines EA; Mannion PA; Evans H; Herrtage ME
J Small Anim Pract; 2001 Mar; 42(3):113-21. PubMed ID: 11303853
[TBL] [Abstract][Full Text] [Related]
40. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome.
van Wijk PA; Rijnberk A; Croughs RJ; Wolfswinkel J; Selman PJ; Mol JA
Eur J Endocrinol; 1994 Apr; 130(4):410-6. PubMed ID: 8162173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
